BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Prognosis
29 results:

  • 1. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
    Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
    Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Survival Benefit of Surgical Treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis.
    Chen K; Yu H; Yang J; Bo Z; Jin C; Wu L; Wang Y; Chen G
    Curr Oncol; 2023 Feb; 30(3):2642-2652. PubMed ID: 36975414
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Somatostatin-analog effect on pancreatic fistula after radical gastrectomy: a pilot randomized controlled trial.
    Sha S; Qiao W; Feng R; Lian G; Chen Y; Peng L; Wang J; Li L; Tian F; Jing C
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6329-6339. PubMed ID: 36745222
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Modern molecular and imaging diagnostics in pancreatic neuroendocrine neoplasms].
    Chiapponi C; Bruns CJ
    Chirurgie (Heidelb); 2022 Aug; 93(8):731-738. PubMed ID: 35913626
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Intraoperative lidocaine infusion in patients undergoing pancreatectomy for pancreatic cancer: a mechanistic, multicentre randomised clinical trial.
    Zhang H; Qu M; Guo K; Wang Y; Gu J; Wu H; Zhu X; Sun Z; Cata JP; Chen W; Miao C
    Br J Anaesth; 2022 Aug; 129(2):244-253. PubMed ID: 35697547
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Real-world comparison of healthcare resource utilization and costs of [
    Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
    Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Autophagic Schwann cells promote perineural invasion mediated by the NGF/ATG7 paracrine pathway in pancreatic cancer.
    Zhang W; He R; Yang W; Zhang Y; Yuan Q; Wang J; Liu Y; Chen S; Zhang S; Zhang W; Zhu Z; Zhang J; Wang Z; Li J
    J Exp Clin Cancer Res; 2022 Feb; 41(1):48. PubMed ID: 35109895
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort.
    Lithgow K; Venkataraman H; Hughes S; Shah H; Kemp-Blake J; Vickrage S; Smith S; Humphries S; Elshafie M; Taniere P; Diaz-Cano S; Dasari BVM; Almond M; Ford S; Ayuk J; Shetty S; Shah T; Geh I
    Sci Rep; 2021 Sep; 11(1):17947. PubMed ID: 34504148
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Heat shock protein 47 confers chemoresistance on pancreatic cancer cells by interacting with calreticulin and IRE1α.
    Yoneda A; Minomi K; Tamura Y
    Cancer Sci; 2021 Jul; 112(7):2803-2820. PubMed ID: 34109710
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. pancreatic cancer Stem-Like Cells With High calreticulin Expression Associated With Immune Surveillance.
    Fujiwara Y; Tsunedomi R; Yoshimura K; Matsukuma S; Fujiwara N; Nishiyama M; Kanekiyo S; Matsui H; Shindo Y; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
    Pancreas; 2021 Mar; 50(3):405-413. PubMed ID: 33835973
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analyzing and predicting the LNM rate and prognosis of patients with intraductal papillary mucinous neoplasm of the pancreas.
    Tang CT; Liu BX; Chen Y; Zeng C
    Cancer Med; 2021 Mar; 10(6):1925-1935. PubMed ID: 33641255
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
    Lembeck AL; Posch F; Klocker EV; Szkandera J; Schlick K; Stojakovic T; Kornprat P; Lackner C; Gerger A; Stoeger H; Stotz M; Pichler M
    Clin Chem Lab Med; 2019 Apr; 57(5):740-744. PubMed ID: 30307891
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Neuroendocrine Neoplasia within the German NET Registry].
    ; ;
    Z Gastroenterol; 2018 Oct; 56(10):1237-1246. PubMed ID: 30304748
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
    El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: An analysis of safety and efficacy.
    Hua YQ; Wang P; Zhu XY; Shen YH; Wang K; Shi WD; Lin JH; Meng ZQ; Chen Z; Chen H
    Pancreatology; 2017; 17(6):967-973. PubMed ID: 29129384
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Pharmacotherapy for pancreatic cancer: Difficulties and prospects].
    Wang ZH; Zhou J; Shen L
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):712-716. PubMed ID: 28926903
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.
    Del Prete M; Di Sarno A; Modica R; Lassandro F; Giorgio A; Bianco A; Muto M; Gasperi M; Del Prete F; Colao A; Montesarchio V; Faggiano A;
    J Endocrinol Invest; 2017 Dec; 40(12):1373-1380. PubMed ID: 28667452
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
    Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
    Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Common CCK-B Receptor Intronic Variant in pancreatic Adenocarcinoma in a Hungarian Cohort.
    Balázs A; Németh BC; Ördög B; Hegyi E; Hritz I; Czakó L; Czimmer J; Gódi S; Csiszkó A; Rakonczay Z; Párniczky A; Izbéki F; Halász A; Kahán Z; Hegyi P; Sahin-Tóth M;
    Pancreas; 2016 Apr; 45(4):541-5. PubMed ID: 26646278
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.